Invention Grant
- Patent Title: Treatment of pulmonary vascular remodeling with neprilysin
-
Application No.: US14510738Application Date: 2014-10-09
-
Publication No.: US09950044B2Publication Date: 2018-04-24
- Inventor: Edward C. Dempsey
- Applicant: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
- Applicant Address: US CO Denver
- Assignee: The Regents of the University of Colorado, a body corporate
- Current Assignee: The Regents of the University of Colorado, a body corporate
- Current Assignee Address: US CO Denver
- Agency: Saul Ewing Arnstein & Lehr LLP
- Agent Kathryn Doyle; Domingos J. Silva
- Main IPC: A61K38/48
- IPC: A61K38/48 ; C12Q1/37 ; A61K48/00 ; A61K31/7088 ; C12N9/64 ; G01N33/573
Abstract:
The present invention relates to agonists of Neprilysin and their use in preventing and treating pulmonary vascular remodeling. Also described are diagnostic and screening applications stemming from the inventor's discovery that Neprilysin is expressed at reduced levels in disease tissues.
Public/Granted literature
- US20150093373A1 TREATMENT OF PULMONARY VASCULAR REMODELING WITH NEPRILYSIN Public/Granted day:2015-04-02
Information query
IPC分类:
